Immunoglobulin for rheumatic diseases in the twenty-first century: take it or leave it?

被引：28

作者：

Braun-Moscovici, Y ^{[1
]}

Furst, DE ^{[1
]}

机构：

[1] Univ Calif Los Angeles, Sch Med, Div Rheumatol, Los Angeles, CA USA

来源：

CURRENT OPINION IN RHEUMATOLOGY | 2003年 / 15卷 / 03期

关键词：

D O I：

10.1097/00002281-200305000-00010

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

There is no simple answer to the question: intravenous immunoglobulin-take it or leave it? A thorough review of the current data on mechanisms of action, efficacy, and safety of intravenous immunoglobulins in rheumatic diseases demonstrates that the answer depends on the disease and the patients involved.

引用

页码：237 / 245

页数：9

共 108 条

[1]

AKASHI K, 1990, J RHEUMATOL, V17, P375

[2]

Al-Mayouf SM, 2000, J RHEUMATOL, V27, P2498

[3] INCLUSION-BODY MYOSITIS - TREATMENT WITH INTRAVENOUS IMMUNOGLOBULIN [J].

AMATO, AA ;

BAROHN, RJ ;

JACKSON, CE ;

PAPPERT, EJ ;

SAHENK, Z ;

KISSEL, JT .

NEUROLOGY, 1994, 44 (08) :1516-1518

[4] Downregulation of TGF-β1 mRNA and protein in the muscles of patients with inflammatory myopathies after treatment with high-dose intravenous immunoglobulin [J].

Amemiya, K ;

Semino-Mora, C ;

Granger, RP ;

Dalakas, MC .

CLINICAL IMMUNOLOGY, 2000, 94 (02) :99-104

[5]

Armentia A, 1993, Allergol Immunopathol (Madr), V21, P47

[6]

Arnal C, 2002, J RHEUMATOL, V29, P75

[7] Mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory diseases [J].

Ballow, M .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 100 (02) :151-157

[8] Modulation of complement-mediated immune damage by intravenous immune globulin [J].

Basta, M .

CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1996, 104 :21-25

[9]

BENCHETRIT E, 1991, J RHEUMATOL, V18, P1635

[10] Intravenous immunoglobulin compared with cyclophosphamide for proliferative lupus nephritis [J].

Boletis, JN ;

Ioannidis, JPA ;

Boki, KA ;

Moutsopoulos, HM .

LANCET, 1999, 354 (9178) :569-570

← 1 2 3 4 5 6 7 8 9 10 →